Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 1
1955 1
1956 1
1957 1
1958 1
1959 1
1961 3
1962 3
1963 10
1964 4
1965 7
1966 8
1967 12
1968 10
1969 11
1970 6
1971 8
1972 11
1973 7
1974 9
1975 7
1976 10
1977 9
1978 12
1979 3
1980 14
1981 23
1982 22
1983 14
1984 19
1985 21
1986 20
1987 20
1988 22
1989 31
1990 39
1991 36
1992 40
1993 40
1994 40
1995 35
1996 44
1997 45
1998 42
1999 48
2000 66
2001 61
2002 65
2003 70
2004 60
2005 64
2006 56
2007 71
2008 77
2009 79
2010 79
2011 90
2012 88
2013 114
2014 118
2015 105
2016 127
2017 129
2018 115
2019 130
2020 155
2021 152
2022 150
2023 142
2024 160
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,028 results

Results by year

Filters applied: . Clear all
Page 1
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).
Watanabe S, Furuya N, Nakamura A, Shiihara J, Nakachi I, Tanaka H, Nakao M, Minato K, Seike M, Sasaki S, Kisohara A, Takeuchi S, Honda R, Takamura K, Kagamu H, Yoshimura K, Kobayashi K, Kikuchi T. Watanabe S, et al. Among authors: kikuchi t. Eur J Cancer. 2024 Jan;197:113469. doi: 10.1016/j.ejca.2023.113469. Epub 2023 Dec 2. Eur J Cancer. 2024. PMID: 38061214 Clinical Trial.
Strongyloides questions-a research agenda for the future.
Al-Jawabreh R, Anderson R, Atkinson LE, Bickford-Smith J, Bradbury RS, Breloer M, Bryant AS, Buonfrate D, Cadd LC, Crooks B, Deiana M, Grant W, Hallem E, Hedtke SM, Hunt V, Khieu V, Kikuchi T, Kounosu A, Lastik D, van Lieshout L, Liu Y, McSorley HJ, McVeigh P, Mousley A, Murcott B, Nevin WD, Nosková E, Pomari E, Reynolds K, Ross K, Streit A, Suleiman M, Tiberti N, Viney M. Al-Jawabreh R, et al. Among authors: kikuchi t. Philos Trans R Soc Lond B Biol Sci. 2024 Jan 15;379(1894):20230004. doi: 10.1098/rstb.2023.0004. Epub 2023 Nov 27. Philos Trans R Soc Lond B Biol Sci. 2024. PMID: 38008122 Free PMC article. Review.
Human proliferative sparganosis update.
Kikuchi T, Maruyama H. Kikuchi T, et al. Parasitol Int. 2020 Apr;75:102036. doi: 10.1016/j.parint.2019.102036. Epub 2019 Dec 10. Parasitol Int. 2020. PMID: 31841658 Free article. Review.
Ebi3 knockout aggravates experimental periodontitis via Th17 polarization.
Goto H, Kikuchi T, Takayanagi Y, Kamiya Y, Suzuki Y, Kawamura S, Sawada N, Hayashi JI, Mitani A. Goto H, et al. Among authors: kikuchi t. J Clin Periodontol. 2023 Oct;50(10):1406-1418. doi: 10.1111/jcpe.13859. Epub 2023 Aug 3. J Clin Periodontol. 2023. PMID: 37534736
Intraoperative Brain Mapping by Cortico-Cortical Evoked Potential.
Yamao Y, Matsumoto R, Kikuchi T, Yoshida K, Kunieda T, Miyamoto S. Yamao Y, et al. Among authors: kikuchi t. Front Hum Neurosci. 2021 Feb 18;15:635453. doi: 10.3389/fnhum.2021.635453. eCollection 2021. Front Hum Neurosci. 2021. PMID: 33679353 Free PMC article. Review.
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab.
Kikuchi T, Takeuchi Y, Nouso K, Kariyama K, Kuwaki K, Toshimori J, Iwado S, Moriya A, Hagihara H, Takabatake H, Tada T, Yasunaka T, Sakata M, Sue M, Miyake N, Adachi T, Wada N, Onishi H, Shiraha H, Takaki A, Otsuka M. Kikuchi T, et al. Liver Int. 2024 Jun;44(6):1456-1463. doi: 10.1111/liv.15907. Epub 2024 Mar 15. Liver Int. 2024. PMID: 38488749
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.
Takahashi M, Watanabe S, Suzuki R, Arita M, Sato K, Sato M, Sekiya Y, Abe Y, Fujisaki T, Ohtsubo A, Shoji S, Nozaki K, Ichikawa K, Kondo R, Saida Y, Hokari S, Aoki N, Hayashi M, Ohshima Y, Koya T, Kikuchi T. Takahashi M, et al. Among authors: kikuchi t. Cancer Immunol Immunother. 2022 Jun;71(6):1357-1369. doi: 10.1007/s00262-021-03078-0. Epub 2021 Oct 17. Cancer Immunol Immunother. 2022. PMID: 34657194 Free PMC article.
3,028 results